ARDX
Ardelyx Inc
Price:  
9.67 
USD
Volume:  
6,892,431.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx EV/EBITDA

-113.9%
Upside

As of 2024-02-28, the EV/EBITDA ratio of Ardelyx Inc (ARDX) is -105.98. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Ardelyx's latest enterprise value is 2,238.29 mil USD. Ardelyx's TTM EBITDA according to its financial statements is -21.12 mil USD. Dividing these 2 quantities gives us the above Ardelyx EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.8x - 15.2x 12.8x
Forward P/E multiples 15.0x - 19.0x 17.2x
Fair Price (1.33) - (1.35) (1.34)
Upside -113.8% - -114.0% -113.9%
9.67 USD
Stock Price
(1.34) USD
Fair Price

Ardelyx EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-27 -105.98
2024-02-26 -101.80
2024-02-23 -95.10
2024-02-22 -96.64
2024-02-21 -93.12
2024-02-20 -93.67
2024-02-16 -99.06
2024-02-15 -101.91
2024-02-14 -101.69
2024-02-13 -97.08
2024-02-12 -106.64
2024-02-09 -106.75
2024-02-08 -101.58
2024-02-07 -98.29
2024-02-06 -99.93
2024-02-05 -98.18
2024-02-02 -97.41
2024-02-01 -101.80
2024-01-31 -95.65
2024-01-30 -97.96
2024-01-29 -103.45
2024-01-26 -99.28
2024-01-25 -97.41
2024-01-24 -93.01
2024-01-23 -94.88
2024-01-22 -96.64
2024-01-19 -90.70
2024-01-18 -88.06
2024-01-17 -93.34
2024-01-16 -96.20
2024-01-12 -98.95
2024-01-11 -95.54
2024-01-10 -99.49
2024-01-09 -99.71
2024-01-08 -89.60
2024-01-05 -67.40
2024-01-04 -66.52
2024-01-03 -67.29
2024-01-02 -66.19
2023-12-29 -67.84
2023-12-28 -70.26
2023-12-27 -71.36
2023-12-26 -70.81
2023-12-22 -69.49
2023-12-21 -68.83
2023-12-20 -64.98
2023-12-19 -72.68
2023-12-18 -68.72
2023-12-15 -64.65
2023-12-14 -63.44